3‐O Sulfated Heparan Sulfate as an Emerging Drug Target and Biomarker for Alzheimer’s Disease
Taken together, our findings underscore the importance of 3-OS in AD pathogenesis, suggesting its potential as a novel drug target and biomarker in Alzheimer's disease.
Authors
- Dylan Mah (ORCID: https://orcid.org/0000-0002-7734-6101)
- Chunyu Wang (ORCID: https://orcid.org/0000-0001-5165-7959)
- Jian Liu (ORCID: https://orcid.org/0000-0002-8969-8446)
- Lianchun Wang (ORCID: https://orcid.org/0000-0001-8709-3622)
- Fuming Zhang
Institutions
- University of North Carolina at Chapel Hill (US)
- Rensselaer Polytechnic Institute (US)
- University of South Florida (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.088959
- Primary Topic
- Phosphodiesterase function and regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00